At INTERPHEX 2025, Michael Franco, international gross sales director at PSG Biotech, spoke with the PharmTech Group about how latest developments in pharmaceutical circulate sensor know-how give attention to bettering measurement accuracy as drug manufacturing turns into dearer and exact. A key growth, he notes, is the enhancement of Coriolis single-use circulate meters, which now characteristic the next turndown ratio. This enhanced characteristic permits a single sensor to precisely measure each excessive and low circulate charges. With this innovation, stock wants could be lowered, and sensor usability throughout numerous course of situations is prolonged, which improves sustainability.
“Once we discuss excessive turndown ratio, it is excellent for the trade, as a result of with one sensor, you possibly can measure extra than simply low flows or excessive flows. So, by way of sustainability, there’s much less want for stock, and the sensor can be utilized for longer, as a result of it may be operated in several course of situations. [In] phrases of the long run, we’re including extra digital communication platforms so clients can talk to the sensors in several methods, ensuring that the sensors speak to pumps, and to get a extremely good efficiency between the 2. [Those] are the issues that most likely are going to be requested increasingly more from clients,” Franco says.
Wanting ahead, this integration of digital communication platforms to boost sensor interoperability is anticipated to allow higher coordination with pumps and optimize system efficiency. These developments are more and more demanded by clients for improved bioprocessing purposes, together with tangential circulate filtration (TFF) and chromatography skids. The continued adoption of those applied sciences as noticed at INTERPHEX, notes Franco, highlights their rising significance in pharmaceutical manufacturing.
INTERPHEX 2025 occurred in New York Metropolis on April 1–3.
Click on above to view the complete interview.
Click on right here for extra convention protection.
In regards to the speaker
Michael Franco is international gross sales director at PSG Biotech.
